1 Year Total Returns (Daily) Chart

View 1 Year Total Returns (Daily) for LEGN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View 1 Year Total Returns (Daily) Chart
Start Trial

Historical 1 Year Total Returns (Daily) Data

View and export this data back to 2021. Start Trial.
Date Value
September 11, 2026 -44.90%
September 10, 2026 -42.67%
September 09, 2026 -41.87%
September 08, 2026 -40.81%
September 04, 2026 -38.50%
September 03, 2026 -39.50%
September 02, 2026 -36.03%
September 01, 2026 -39.16%
August 31, 2026 -40.17%
August 28, 2026 -42.16%
August 27, 2026 -40.96%
August 26, 2026 -41.05%
August 25, 2026 -38.44%
August 24, 2026 -41.11%
August 21, 2026 -38.59%
August 20, 2026 -40.33%
August 19, 2026 -38.15%
August 18, 2026 -41.47%
August 17, 2026 -44.93%
August 14, 2026 -45.98%
August 13, 2026 -45.11%
August 12, 2026 -44.17%
August 11, 2026 -39.76%
August 10, 2026 -44.16%
August 07, 2026 -44.56%
Date Value
August 06, 2026 -48.81%
August 05, 2026 -50.42%
August 04, 2026 -50.25%
August 03, 2026 -51.01%
July 31, 2026 -52.52%
July 30, 2026 -52.86%
July 29, 2026 -53.76%
July 28, 2026 -54.13%
July 27, 2026 -55.56%
July 24, 2026 -49.74%
July 23, 2026 -46.91%
July 22, 2026 -46.55%
July 21, 2026 -44.26%
July 20, 2026 -44.19%
July 17, 2026 -47.16%
July 16, 2026 -42.87%
July 15, 2026 -41.80%
July 14, 2026 -34.91%
July 13, 2026 -33.91%
July 10, 2026 -31.81%
July 09, 2026 -30.60%
July 08, 2026 -25.66%
July 07, 2026 -22.83%
July 06, 2026 -21.32%
July 02, 2026 -16.71%

Total Return Definition

The Total return is the change in price over a specific period of time that includes dividends and distributions paid.

Read full definition.

1 Year Total Returns (Daily) Range, Past 5 Years

View 1 Year Total Returns (Daily) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

1 Year Total Returns (Daily) Benchmarks

View 1 Year Total Returns (Daily) Benchmarks
Start Trial
Gilead Sciences, Inc. 25.13%
Arbutus Biopharma Corp. 4.49%
AbbVie, Inc. 20.38%
TG Therapeutics, Inc. 66.02%
Capricor Therapeutics, Inc. 29.97%